Clinical trials
Charité – Universitätsmedizin Berlin is constantly conducting clinical trials.
Are you interested in participating in a clinical trial? Below you will find information on all current and planned clinical trials at Charité.
You are here:
Filter results
Quality of life in patients with short bowel syndrome treated without and with teduglutide – a prospective nested matched- pair analysis
Short title: QoL in IF patients
Investigated disease: Kurzdarmsyndrom
Principal Investigator: Dr. med. Elisabeth Blüthner
Patient (diseased)
Age: 18 - 100
Gender: All
Status: Participants wanted
A randomized, treatment open-label, dose-blinded parallel group, three arm, proof-of-concept clinical trial to investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy
Short title: LNP023 & membr. GN
Investigated disease: membranöse GN
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
Short title: LNP023 & IgANP
Investigated disease: Iga Nephropathy
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
REMAP-CAP
Short title: REMAP-CAP
Investigated disease: Pneumonia ICU
Principal Investigator: Dr. med. Andre Finn
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Short title: GALAXI
Investigated disease: Morbus Crohn
Principal Investigator: Dr. med. Anja Schirbel
Patient (diseased)
Age: 18 - 80
Gender: All
Status: Participants wanted
Liberale Transfusionsstrategie zur Prävention von Sterblichkeit und Anämie-assoziierten, ischämischen Ereignissen bei älteren, nicht-herzchirurgischen Patienten
Short title: LIBERAL-Trial
Investigated disease: perioperative anaemia
Principal Investigator: Prof. Dr. Sascha Treskatsch
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
The role of pre-formed alloreactive T cells on acute rejection episodes and long-term graft outcome in patients after living donor renal transplantation
Short title: ALLO
Investigated disease: The role of pre-formed alloreactive T cells
Principal Investigator: Prof. Dr. Klemens Budde
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
Morbus Farby neue Therapien
Short title: Migalastat Beob. Stu
Investigated disease: Morbus Fabry
Principal Investigator: Dr. Sima Canaan-Kühl
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy
Short title: PIONEER
Principal Investigator: PD Dr. Frank Siebenhaar
Patient (diseased)
Age: 18
Gender: All
Status: Study in preparation
Einfluss eines Probiotikums auf den Blutdruck von Patienten mit Hypertonie Grad 1 - eine randomisierte klinische Studie (HYPRO)
Short title: HYPRO
Investigated disease: Essentielle Hypertonie Grad 1 (>140/90 mmHg)
Principal Investigator: Dr. med. Michael Boschmann
Patient (diseased)
Age: 50 - 75
Gender: All